Brooks Laboratories

Chandigarh, India Founded: 2002 • Age: 24 yrs
Manufacturer of pharmaceutical injectables, tablets, and oral suspensions
Annual revenue $9.6M Latest available
Total funding - Funding intelligence
Employees 323 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Brooks Laboratories

Brooks Laboratories is a company based in Chandigarh (India) founded in 2002. The company has 323 employees as of March 31, 2024. Brooks Laboratories offers products and services including Antibiotics and Injections.

  • Headquarter Chandigarh, India
  • Employees 323 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Brooks Laboratories Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $9.62 M (USD)
    3.91
    as on Mar 31, 2024
  • Net Profit
    -$1.16 M (USD)
    49.13
    as on Mar 31, 2024
  • EBITDA
    $556.19 K (USD)
    60.19
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    323

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Brooks Laboratories

Brooks Laboratories is a publicly listed company on the NSE with ticker symbol BROOKS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: BROOKS · Sector: Health technology · India

Products & Services of Brooks Laboratories

Brooks Laboratories offers a comprehensive portfolio of products and services, including Antibiotics and Injections.

Product name locked
Category locked
Primary

Antibiotics and related formulations are manufactured and distributed for therapeutic use.

Product name locked
Category locked
Locked

Liquid, dry powder, and lyophilized injections are produced for various medical applications.

Funding Insights of Brooks Laboratories

Premium access

Detailed funding history for Brooks Laboratories

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Brooks Laboratories

Investments
Premium access

Investment portfolio details for Brooks Laboratories

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Brooks Laboratories

Premium access

Detailed financials for Brooks Laboratories

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Brooks Laboratories Comparisons

Brooks Laboratories Primary company
Description
Manufacturer of pharmaceutical injectables, tablets, and ora...
Location
Chandigarh, India
Founded Year
2002
Annual Revenue
$9.62 M (USD)
Net Profit
-$1.16 M (USD)
EBITDA
$556.19 K (USD)
Employees
323
As of 2024
Premium access

Peer comparison for Brooks Laboratories

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Brooks Laboratories

Premium access

Detailed competitors of Brooks Laboratories

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Brooks Laboratories

Premium access

Complete news archive for Brooks Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brooks Laboratories

Brooks Laboratories was founded in 2002.

Brooks Laboratories is headquartered in Chandigarh, India.

Rajnish Kumar Bedi is the current CEO of Brooks Laboratories.

As of Mar 31, 2024, the latest employee count at Brooks Laboratories is 323.

Annual revenue of Brooks Laboratories is $9.62M as on Mar 31, 2024.

Founded in 2002 and based in Chandigarh, India, the company operates in the pharmaceutical sector. Formulations across therapeutic areas such as antibiotics and pain management are developed, manufactured, and marketed. Products, including injectables, tablets, and oral suspensions, are distributed domestically and internationally. GMP certifications and accreditations are held, with manufacturing processes maintained under strict quality control standards.

Brooks Laboratories offers Antibiotics and Injections.

Yes, Brooks Laboratories is publicly traded on NSE under the ticker symbol BROOKS.

The ticker symbol of Brooks Laboratories is BROOKS on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available